Squarepoint’s Aptose Biosciences, Inc. APTO Stock Holding History

Squarepoint’s Portfolio APTO Stock Details APTO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-44	Closed	-$27K	–	3759
2021 Q4	$27K	Buy	44 +10	+29%	+$9.4K	﹤0.01%	3077
2021 Q3	$34K	Buy	+34	New	+$42.5K	﹤0.01%	2803
2021 Q1	–	Sell	-29	Closed	-$57K	–	3775
2020 Q4	$57K	Buy	+29	New	+$68.1K	﹤0.01%	2796
2019 Q3	–	Sell	-66	Closed	-$78K	–	2768
2019 Q2	$78K	Buy	66 +2	+3%	+$1.84K	﹤0.01%	2251
2019 Q1	$58K	Buy	+64	New	+$57.9K	﹤0.01%	2074

Other funds holding APTO

DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

SMH

Sanders Morris Harris Houston, Texas $172M AUM 22.54% 1-Year Est. Return

Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SPC

Sigma Planning Corp Ann Arbor, Michigan $3.6B AUM 24.57% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Squarepoint's APTO Position: Q1 2022 in Review

Squarepoint sold out of Aptose Biosciences, Inc. (APTO) in Q1 2022, closing a stake of 44 shares — an estimated $27K sold.

Squarepoint first reported a position in APTO in Q1 2019 and held it in 5 quarters. The position peaked at $78K in Q2 2019. 52 funds tracked by Wall St. Rank hold APTO as of Q1 2022.

Squarepoint reported no remaining Aptose Biosciences, Inc. position as of Q1 2022 after selling out during the quarter.
Squarepoint sold 44 Aptose Biosciences, Inc. shares in Q1 2022, an estimated $27K.
Squarepoint first reported a position in Aptose Biosciences, Inc. in Q1 2019 and held it in 5 quarters.
Squarepoint's Aptose Biosciences, Inc. position peaked at $78K in Q2 2019.
52 funds tracked by Wall St. Rank held Aptose Biosciences, Inc. as of Q1 2022.

Based on Squarepoint's 13F filing for Q1 2022, filed 16 May 2022.